In this article, we will discuss the Goldman Sachs Healthcare Stocks: Top 10 Stock Picks. The healthcare sector, long seen as ...

Pfizer (PFE) looks undervalued at 8–9x forward earnings with a ~7% yield; see how Seagen, cost cuts and the pipeline could drive $36–42 upside—read now.

Shares of Pfizer Inc. PFE slid 1.04% to $26.58 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.61% to 6,632.19 and Dow Jones ...

Shantanu Narayen led Adobe through a transition to subscription software, and he's been positioning the company to grow in the artificial intelligence age.

The stock now trades at a dividend yield of 6.5%. Despite continued pricing pressure, Pfizer stock looks cheap for investors today. Investors may have thought they were out of the woods as Pfizer ...

This darling of the Covid era has given back considerable gains in recent years, but it could be on the verge of a turnaround ...

On March 6, Reuters reported that China has approved Pfizer Inc. (NYSE:PFE)’s GLP-1 treatment Xianweiying for long-term weight management in overweight or obese adults.

BioNTech (BNTX) stock tumbles 17% after reporting Q4 losses, missing 2026 revenue projections, and announcing co-founder departures. Full analysis here.

Learn more about whether Halozyme Therapeutics, Inc. or Tango Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Investor sentiment toward Pfizer remains cautious despite a significant development in its dermatology pipeline. The pharmaceutical giant announced accelerated ...

Pfizer (NYSE: PFE) recently reported earnings, and its payout ratio is once again over 100%. Given that the stock is paying a fairly high yield of 6.4%, which is far above the S&P 500 average of 1.2%, ...

Northrop Grumman (NOC), [RTX (RTX)](https ...